Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 12026-09-08NCT03006172

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Genentech, Inc.221

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Columbia University Medical centerNew YorkUnited States224
Dana Farber Cancer InstituteBostonUnited States300
Hospital Clinico Universitario de ValenciaValenciaSpain109
Hospital Universitari Vall d'HebronBarcelonaSpain200
Institut BergonieBordeauxFrance53
Institut Gustave RoussyVillejuifFrance113
Massachusetts General Hospital.BostonUnited States5
Memorial Sloan Kettering Cancer CenterNew YorkUnited States5
Princess Margaret HospitalTorontoCanada3
Royal Marsden Hospital - SurreySurreyUnited Kingdom1
Scri Oncology PartnersNashvilleUnited States156
St Bartholomew's HospitalLondonUnited Kingdom1